Founded by renowned and experienced African biostatisticians, Optima Clinical aims to revolutionize data management and ...

A federal judge said Amgen must face a proposed class action accusing the drugmaker of waiting too long to tell shareholders ...

Family Heart Foundation unveiled the Cholesterol Connect program for LDL-C Awareness Day, aiming to make it easier for people ...

Among biopharma firms, size didn’t always correlate with the highest wages, a recently debuted analysis of ‘best’ pharma ...

On August 23, 2024, the FDA approved Amgen’s aflibercept biosimilar PAVBLU (aflibercept-ayyh), a biosimilar of Regeneron’s EYLEA®. According to the approval letter, “Pavblu is indicated for ...

Otulfi was approved simultaneously in the European Union. In the US, it will launch in February 2025.

And yet, outside of the big ticket events, the overall importance of our local tourism and hospitality sector is still ...

Roche (OTCQX:RHHBY) said Monday that three obesity and diabetes drug candidates acquired through its takeover of Carmot ...

In a 3-year extension of the pivotal trials that provided lebrikizumab with an indication for atopic dermatitis, the response ...

Shane Lowry has had a solid if unspectacular run since returning to the DP World Tour, but he enjoyed a memorable Spanish ...